3-Methylglutaconic Aciduria Type VIIB — Rare Hereditary Metabolic Disorder with Antenatal Onset: Clinical Case
https://doi.org/10.15690/vsp.v24i2.2892
Abstract
Background. 3-methylglutaconic aciduria (3-MGA), type VIIB is a rare hereditary disease with onset in the antenatal period, extremely severe course, and unfavorable outcome. This form of aciduria has not been previously described in Russian Federation. Clinical case description. Severe neonatal 3-MGA caused by pathogenic allele in the CLPB gene manifested in a newborn child with non-epileptic motor disorders (tremor, myoclonus) along with seizures resistant to therapy, and severe neutropenia. Bacterial infection with pneumonia and chylothorax development was observed. The specific feature of this case is the absence of cataract typical for 3-MGA, type VIIB, but presence of hypoparathyroidism, that was not previously described as the manifestations of this disease. Diagnosis 3-MGA, type VIIB, was confirmed by whole-genome sequencing. Two variants of the CLPB gene (NM_001258392.3) were revealed: HG38 variant (chr11-72301838C>CT, c.1293dup) in heterozygous state leading to frameshift and premature stop codon (p.Asp432Argfs*11), and novel HG38 variant (chr11-72294617T>TA, c.1560+2dup) in heterozygous state leading to changes in splice donors. The child died at the age of 1 month and 6 days despite intensive multicomponent management. Conclusion. Pathological motor activity of the intrauterine child combined with neonatal motor impairment and neutropenia are sufficient basis for whole-genome sequencing to establish etiological diagnosis. The types of 3-MGA inheritance correlate with different disease prognosis, thus, it is crucial to examine proband’s parents to evaluate the risks of sick children birth.
Keywords
About the Authors
Irina A. BelyaevaRussian Federation
Moscow
Disclosure of interest:
Irina A. Belyaeva — lecturing for pharmaceutical companies Progress, Bayer, AstraZeneca, Abbott Laboratories, Hero Rus, SVITMILK
Anna L. Karpova
Russian Federation
Moscow; Yaroslavl
Disclosure of interest:
Ather authors confirmed the absence of a reportable conflict of interests
Maria G. Degtyareva
Russian Federation
Moscow
Disclosure of interest:
Ather authors confirmed the absence of a reportable conflict of interests
Andrey Yu. Kruglyakov
Russian Federation
Moscow
Disclosure of interest:
Ather authors confirmed the absence of a reportable conflict of interests
Mikhail M. Kamenev
Russian Federation
Moscow
Disclosure of interest:
Ather authors confirmed the absence of a reportable conflict of interests
Tatyana A. Tenovskaya
Russian Federation
Moscow
Disclosure of interest:
Ather authors confirmed the absence of a reportable conflict of interests
Anastasiya V. Sheremetyeva
Russian Federation
Moscow
Disclosure of interest:
Ather authors confirmed the absence of a reportable conflict of interests
References
1. Flora V. Glavnyi neonatolog Minzdrava rasskazal, chem chashche vsego boleyut rossiiskie mladentsy. Rossiiskaya Federatsiya segodnya. 2023;(4):82–85. (In Russ).
2. Ling SY, Yu Y, Qiu WJ, et al. Analysis of six children with 3-methylglutaconic aciduria. Zhonghua Er Ke Za Zhi. 2021;59(8):695–699. doi: https://doi.org/10.3760/cma.j.cn112140-20210202-00094
3. Itonaga T, Maeda M, Koga H, et al. Asymptomatic 3-methylglutaconic aciduria type 1 detected by high C5-OH on newborn screening. Mol Genet Metab Rep. 2023;38:101024. doi: https://doi.org/10.1016/j.ymgmr.2023.101024
4. Bizjak N, Zerjav Tansek M, Avbelj Stefanija M, et al. Precocious puberty in a girl with 3-methylglutaconic aciduria type 1 (3-MGA-I) due to a novel AUH gene mutation. Mol Genet Metab Rep. 2020;25:100691. doi: https://doi.org/10.1016/j.ymgmr.2020.100691
5. Nardecchia F, Caciotti A, Giovanniello T, et al. 3-Methylglutaconic Aciduria Type I Due to AUH Defect: The Case Report of a Diagnostic Odyssey and a Review of the Literature. Int J Mol Sci. 2022;23(8):4422. doi: https://doi.org/10.3390/ijms23084422
6. #616271. 3-METHYLGLUTACONIC ACIDURIA, TYPE VIIB. In: OMIM — Online Mendelian Inheritance in Man: Official website. Available online: https://omim.org/entry/616271. Accessed on January 14, 2025.
7. Wortmann SB, Ziętkiewicz S, Kousi M, et al. CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder. Am J Hum Genet. 2015;96(2):245–257. doi: https://doi.org/10.1016/j.ajhg.2014.12.013
8. 3-Methylglutaconic Aciduria Overview. Genetic and Rare Diseases Information Center. In: GARD — Genetic and Rare Diseases Information Center: Official website. Available online: https://rarediseases.info.nih.gov/diseases/17767/x. Accessed on January 14, 2025.
9. Pronicka E, Ropacka-Lesiak M, Trubicka J, et al. A scoring system predicting the clinical course of CLPB defect based on the foetal and neonatal presentation of 31 patients. J Inherit Metab Dis. 2017;40(6):853–860. doi: https://doi.org/10.1007/s10545-017-0057-z
10. Wortmann SB, Wevers RA. CLPB Deficiency. In: GeneReviews® [Internet]. Adam MP, Feldman J, Mirzaa GM, et al., eds. Seattle (WA): University of Washington, Seattle; 1993–2025. Available online: https://www.ncbi.nlm.nih.gov/books/NBK396257. Accessed on January 14, 2025.
11. Kanabus M, Shahni R, Saldanha JW, et al. Bi-allelic CLPB mutations cause cataract, renal cysts, nephrocalcinosis and 3-methylglutaconic aciduria, a novel disorder of mitochondrial protein disaggregation. J Inherit Metab Dis. 2015;38(2):211–219. doi: https://doi.org/10.1007/s10545-015-9813-0
12. Karpova AL, Narogan MV, Mostovoy AV, et al. Umbilical cord blood glucose levels in full-term newborns. Rossiyskiy Vestnik Perinatologii i Pediatrii = Russian Bulletin of Perinatology and Pediatrics. 2014;59(2):54–56. (In Russ).
13. 3-Methylglutaconic Aciduria Type VII. In: Orphanet. Available online: https://www.orpha.net/en/disease/detail/445038?name=%23%20616271&mode=omim. Accessed on January 14, 2025.
14. Jones DE, Klacking E, Ryan RO. Inborn errors of metabolism associated with 3-methylglutaconic aciduria. Clin Chim Acta. 2021;522:96–104. doi: https://doi.org/10.1016/j.cca.2021.08.016
15. Gamisoniya A. 3-metilglutakonovaya atsiduriya tip I. Genokarta: geneticheskaya entsiklopediya: Official website.
16. Gamisoniya A. 3-metilglutakonovaya atsiduriya tip V. Genokarta: geneticheskaya entsiklopediya: Official website.
17. Rivalta B, Torraco A, Martinelli D, et al. Biallelic CLPB mutation associated with isolated neutropenia and 3-MGA-uria. Pediatr Allergy Immunol. 2022;33(5):e13782. doi: https://doi.org/10.1111/pai.13782
18. Wortmann SB, Ziętkiewicz S, Guerrero-Castillo S, et al. Neutropenia and intellectual disability are hallmarks of biallelic and de novo CLPB deficiency. Genet Med. 2021;23(9):1705–1714. doi: https://doi.org/10.1038/s41436-021-01194-x
19. Capo-Chichi JM, Boissel S, Brustein E, et al. Disruption of CLPB is associated with congenital microcephaly, severe encephalopathy and 3-methylglutaconic aciduria. J Med Genet. 2015;52(5): 303–311. doi: https://doi.org/10.1136/jmedgenet-2014-102952
20. Huang Z, Liu Y, Huang X, et al. Newborn screening for 3-hydroxy-3-methylglutaric aciduria using direct analysis in realtime mass spectrometry. J Mass Spectrom. 2019;54(2):134–140. doi: https://doi.org/10.1002/jms.4314
21. Wanders RJ, Schutgens RB, Zoeters BH. Prenatal diagnosis of 3-hydroxy-3-methylglutaric aciduria via enzyme activity measurements in chorionic villi, chorionic villous fibroblasts or amniocytes using a simple spectrophotometric method. J Inherit Metab Dis. 1988;11(4):430. doi: https://doi.org/10.1007/BF01800436
Review
For citations:
Belyaeva I.A., Karpova A.L., Degtyareva M.G., Kruglyakov A.Yu., Kamenev M.M., Tenovskaya T.A., Sheremetyeva A.V. 3-Methylglutaconic Aciduria Type VIIB — Rare Hereditary Metabolic Disorder with Antenatal Onset: Clinical Case. Current Pediatrics. 2025;24(2):96-104. (In Russ.) https://doi.org/10.15690/vsp.v24i2.2892